iHuman (IH) Cash Flow: Operating & Free Cash Flow

iHuman (IH) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), iHuman generated CNY 51.32M of operating cash flow and spent CNY 4.90M on capital expenditures. That left free cash flow of CNY 46.41M, down 9.2% from CNY 51.10M a year earlier, or 5.8% of revenue. It returned CNY 56.27M to shareholders through CNY 39.09M in dividends and CNY 17.19M in share buybacks.

iHuman Cash Flow Statement Analysis

Values in billions CNY

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for iHuman Inc. (IH) - Annual data in billions CNY
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Mar 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Operating Activities
Net Income	0.10	0.10	0.18	0.75	0.11	-0.04	-0.04	-0.28	-0.02
Depreciation & Amortization	0.01	0.01	0.01	0.07	0.01	0.01	0.00	0.00	0.00
Deferred Income Tax	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Stock Based Compensation	0.00	0.00	0.01	0.09	0.01	0.02	0.08	0.27	0.00
Change in Working Capital	-0.06	-0.06	-0.04	0.18	0.03	0.03	0.17	0.05	0.01
Change in Accounts Receivable	0.00	0.01	0.02	-0.20	-0.02	0.02	-0.06	-0.01	-0.01
Change in Inventory	0.00	-0.01	0.00	0.05	0.01	-0.01	0.00	0.01	0.00
Change in Accounts Payable	-0.01	0.01	0.00	-0.04	-0.01	0.02	0.01	0.00	0.00
Change in Other Working Capital	0.02	0.00	0.01	0.37	0.02	0.02	0.01	0.05	0.02
Other Operating Activities	0.00	0.00	0.01	0.20	0.02	0.02	0.01	0.00	0.00
Net Cash from Operating Activities	0.05	0.06	0.17	1.29	0.19	0.04	0.22	0.04	0.00
Investing Activities
Capital Expenditures	0.00	-0.01	-0.01	-0.05	-0.01	-0.03	-0.02	0.00	0.00
Purchases of Investments	-0.67	-0.25	-0.38	-1.71	-0.25	0.00	0.00	0.00	0.00
Sales/Maturities of Investments	0.72	0.21	0.38	1.53	0.22	0.00	0.00	0.00	0.00
Other Investing Activities	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Net Cash from Investing Activities	0.04	-0.05	-0.01	-0.23	-0.03	-0.03	-0.02	0.00	0.00
Financing Activities
Common Stock Issued	0.00	0.00	0.00	0.00	0.00	0.00	0.63	0.12	0.00
Common Stock Repurchased	-0.02	-0.01	-0.01	-0.01	-0.01	0.00	0.00	0.00	0.00
Dividends Paid	-0.04	-0.04	0.00	0.00	-	0.00	-0.07	0.00	-0.01
Other Financing Activities	0.00	-0.06	0.00	-0.04	-	0.00	-0.06	-0.06	0.02
Net Cash from Financing Activities	-0.06	-0.10	-0.01	-0.05	-0.01	0.00	0.57	0.06	0.01
Summary
Effect of Forex Changes on Cash	-0.01	0.01	0.01	0.31	0.05	-0.01	-0.02	0.00	0.00
Net Change in Cash	0.03	-0.09	0.16	1.33	0.19	0.01	0.76	0.10	0.01
Cash at Beginning of Period	1.08	1.21	1.05	5.86	0.86	0.86	0.10	0.01	0.00
Cash at End of Period	1.15	1.12	1.21	7.19	1.05	0.86	0.86	0.10	0.01
Free Cash Flow	0.05	0.05	0.17	1.25	0.18	0.01	0.21	0.04	-0.01
Supplemental Disclosures
Income Taxes Paid	-	0.02	0.02	-	0.01	0.00	0.00	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About iHuman Cash Flow

What is iHuman's free cash flow?

iHuman generated free cash flow of CNY 46.41M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of CNY 51.32M minus CNY 4.90M of capital expenditures. That was down 9.2% from CNY 51.10M a year earlier. Free cash flow equaled 5.8% of revenue.

How much does iHuman spend on capital expenditures?

iHuman spent CNY 4.90M on capital expenditures in fiscal 2025, compared with CNY 7.45M a year earlier. That equals 9.6% of operating cash flow.

Does iHuman pay dividends or buy back shares?

Yes. In fiscal 2025 iHuman returned CNY 39.09M in dividends and CNY 17.19M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition